BAC
GSK icon

Boys Arnold & Co’s GSK GSK Stock Holding History

Boys Arnold & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,480
Closed -$524K – 275
2019
Q2 		$524K Hold
10,480
– – 0.08% 191
2019
Q1 		$547K Hold
10,480
– – 0.08% 186
2018
Q4 		$500K Hold
10,480
– – 0.08% 188
2018
Q3 		$526K Hold
10,480
– – 0.07% 194
2018
Q2 		$528K Sell
10,480
-293
-3% -$14.8K 0.08% 199
2018
Q1 		$539K Sell
10,773
-120
-1% -$5.59K 0.08% 199
2017
Q4 		$483K Sell
10,893
-1,097
-9% -$50.7K 0.07% 212
2017
Q3 		$608K Buy
11,990
+480
+4% +$24.4K 0.1% 183
2017
Q2 		$620K Sell
11,510
-212
-2% -$11.3K 0.08% 179
2017
Q1 		$618K Buy
11,722
+666
+6% +$33.8K 0.1% 173
2016
Q4 		$532K Hold
11,056
– – 0.09% 186
2016
Q3 		$596K Sell
11,056
-229
-2% -$12.6K 0.1% 169
2016
Q2 		$611K Buy
+11,285
New +$595K 0.11% 160
2015
Q4 		– Sell
-11,016
Closed -$529K – 219
2015
Q3 		$529K Buy
11,016
+56
+0.5% +$2.92K 0.11% 150
2015
Q2 		$571K Hold
10,960
– – 0.11% 148
2015
Q1 		$632K Sell
10,960
-80
-0.7% -$4.59K 0.12% 145
2014
Q4 		$590K Sell
11,040
-136
-1% -$7.61K 0.11% 141
2014
Q3 		$642K Sell
11,176
-960
-8% -$58.9K 0.13% 136
2014
Q2 		$811K Sell
12,136
-560
-4% -$37.9K 0.14% 137
2014
Q1 		$848K Hold
12,696
– – 0.15% 123
2013
Q4 		$847K Hold
12,696
– – 0.16% 111
2013
Q3 		$796K Buy
12,696
+136
+1% +$8.76K 0.17% 109
2013
Q2 		$785K Buy
+12,560
New +$797K 0.17% 107

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Boys Arnold & Co's GSK Position: Q3 2019 in Review

Boys Arnold & Co sold out of GSK (GSK) in Q3 2019, closing a stake of 10,480 shares — an estimated $524K sold.

Boys Arnold & Co first reported a position in GSK in Q2 2013 and held it in 23 quarters. The position peaked at $848K in Q1 2014. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Boys Arnold & Co reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Boys Arnold & Co sold 10,480 GSK shares in Q3 2019, an estimated $524K.
  • Boys Arnold & Co first reported a position in GSK in Q2 2013 and held it in 23 quarters.
  • Boys Arnold & Co's GSK position peaked at $848K in Q1 2014.
  • 806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Boys Arnold & Co's 13F filing for Q3 2019, filed 24 Oct 2019.